Amgen Inc.
Explore Amgen Inc.
Core profile pages, annual revenue records, and related research hubs for this company.
CorpDigest
Amgen Inc.
Explore Amgen Inc.
Core profile pages, annual revenue records, and related research hubs for this company.
Annual Revenue
FY2022 Revenue
$26.3B
▲ 1.3% vs FY2021 ($26.0B)
Source: Annual report / company filing
Amgen Inc. reported $26.3B in revenue for fiscal year 2022. This represents a growth of 1.3% compared to the 2021 figure of $26.0B. In 2023, revenue increased to $28.2B.
Near-flat as biosimilar competition pressured older franchises.
| Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2025 | $36.8B | — | +10.0% |
| FY2024 | $33.4B | $3.8B | +18.6% |
| FY2023 | $28.2B | — | +7.1% |
| FY2022 | $26.3B | — | +1.3% |
| FY2021 | $26.0B | — | +2.2% |
| FY2020 | $25.4B | — | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.